Author:
Peng Jianhua,Ghosh Dipritu,Zhang Fan,Yang Lei,Wu Jinpeng,Pang Jinwei,Zhang Lifang,Yin Shigang,Jiang Yong
Abstract
A wide plethora of intervention procedures, tissue plasminogen activators, mechanical thrombectomy, and several neuroprotective drugs were reported in stroke research over the last decennium. However, against this vivid background of newly emerging pieces of evidence, there is little to no advancement in the overall functional outcomes. With the advancement of epigenetic tools and technologies associated with intervention medicine, stroke research has entered a new fertile. The stroke involves an overabundance of inflammatory responses arising in part due to the body’s immune response to brain injury. Neuroinflammation contributes to significant neuronal cell death and the development of functional impairment and even death in stroke patients. Recent studies have demonstrated that epigenetics plays a key role in post-stroke conditions, leading to inflammatory responses and alteration of the microenvironment within the injured tissue. In this review, we summarize the progress of epigenetics which provides an overview of recent advancements on the emerging key role of secondary brain injury in stroke. We also discuss potential epigenetic therapies related to clinical practice.
Reference124 articles.
1. Histone deacetylases as therapeutic targets–from cancer to cardiac disease.;Abend;Pharmacol. Ther.,2015
2. Modified nucleosides and bizarre 5′-termini in mouse myeloma mRNA.;Adams;Nature,1975
3. Methylation of nuclear simian virus 40 RNAs.;Aloni;J. Virol.,1979
4. Effect of area-based deprivation on the severity, subtype, and outcome of ischemic stroke.;Aslanyan;Stroke,2003
5. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: An ecological analysis from the Global Burden of Disease Study 2017.;Avan;BMC Med.,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献